Atherothrombotic risk factor clustering in healthy male relatives of male patients with intermittent claudication

Journal of Vascular Surgery

Volumn 40, Issue 5, 2004, Pages 891-898

  Parry, Duncan J ^a   Grant, Peter J ^b   Scott, D Julian A ^a  

^a St James's Hospital   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13B; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; PROTEIN SUBUNIT; VON WILLEBRAND FACTOR;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLUSTER ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INTERMITTENT CLAUDICATION; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OUTCOMES RESEARCH; PREMATURITY; PRIORITY JOURNAL; RACE; RELATIVE; SEX; THROMBOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DISEASE SUSCEPTIBILITY; FACTOR VII; GREAT BRITAIN; HUMANS; INCIDENCE; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PEDIGREE; RISK FACTORS; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; VON WILLEBRAND FACTOR;

EID: 8844256209     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2004.08.021     Document Type: Article

References (47)

1. A.P. Schroeder, E. Falk Vulnerable and dangerous coronary plaques Atherosclerosis 118 suppl 1995 S141 9
2. J. Heinrich, L. Balleisen, H. Schulte, G. Assmann, L.J. van de Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men Arterioscler Thromb 14 1994 54 59
3. T.W. Meade, V. Ruddock, Y. Stirling, R. Chakrabarti, G.J. Miller Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 342 1993 1076 1079
4. T.W. Meade, S. Mellows, M. Brozovic, G.J. Miller, R.R. Chakrabarti, W.R.S. North Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study Lancet 2 1986 533 537
5. T.W. Meade, J.A. Cooper, Y. Stirling, D.J. Howarth, V. Ruddock, G.J. Miller Factor VIII, ABO blood group and the incidence of ischaemic heart disease Br J Haematol 88 1994 601 607
6. M.W. Mansfield, H.P. Kohler, R.A. Ariens, L.J. McCormack, P.J. Grant Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives Diabetes Care 23 2000 703 705
7. H.P. Kohler, R.A. Ariens, M.W. Mansfield, P. Whitaker, P.J. Grant Factor XIII activity and antigen levels in patients with coronary artery disease Thromb Haemost 85 2001 569 570
8. G.M. Reaven Banting lecture 1988 Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
9. J.D. Mills, P.J. Grant Insulin resistance, haemostatic factors and cardiovascular disease Br J Diabetes Vasc Dis 2 2002 19 26
10. J.M. Boer, E.J. Feskens, W.M. Verschuren, J.C. Seidell, D. Kromhout The joint impact of family history of myocardial infarction and other risk factors on 12-year coronary heart disease mortality Epidemiology 10 1999 767 770
11. M. Hippe, J. Vestbo, H.O. Hein, K. Borch-Johnsen, G. Jensen, T.I. Sorensen Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction J Epidemiol Commun Health 53 1999 269 276
12. M.E. Marenberg, N. Risch, L.F. Berkman, B. Floderus, U. De Faire Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1994 1041 1046
13. J.C. Souto, L. Almasy, M. Borrell, M. Gari, E. Martinez, J. Mateo Genetic determinants of hemostasis phenotypes in Spanish families Circulation 101 2000 1546 1551
14. R.J. Valentine, R. Verstraete, G.P. Clagett, J.C. Cohen Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis Arch Intern Med 160 2000 1343 1348
15. R.J. Valentine, R. Guerra, P. Stephan, E. Scoggins, G.P. Clagett, J. Cohen Family history is a major determinant of subclinical peripheral arterial disease in young adults J Vasc Surg 39 2004 351 356
16. M. Hippe, J. Vestbo, A.M. Bjerg, K. Borch-Johnsen, M. Appleyard, H.O. Hein Cardiovascular risk factor profile in subjects with familial predisposition to myocardial infarction in Denmark J Epidemiol Commun Health 51 1997 266 271
17. J.D. Mills, M.W. Mansfield, P.J. Grant Factor XIII: circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease Thromb Haemost 87 2002 409 414
18. J.D. Mills, M.W. Mansfield, P.J. Grant Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease Eur Heart J 23 2002 1276 1281
19. M.W. Mansfield, D.M. Heywood, P.J. Grant Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM Circulation 94 1996 2171 2176
20. G.C. Leng, F.G. Fowkes The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys J Clin Epidemiol 45 1992 1101 1109
21. G. Rose, P. McCartney, D.D. Reid Self-administration of a questionnaire on chest pain and intermittent claudication Br J Prevent Social Med 31 1977 42 48
22. E.F. Bernstein, A. Fronek Current status of noninvasive tests in the diagnosis of peripheral arterial disease Surg Clin North Am 62 1982 473 487
23. Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications 1999 World Health Organization, Department of Non-Communicable Disease Surveillance Geneva, Switzerland p 2-48
24. G.A. Marbet, F. Duckert Fibrinogen J. Jesperson R.M. Bertina G. Haverkate ECAT assay procedures: a manual of laboratory techniques 1992 Kluwer Academic London, England p 47 56
25. R.A. Ariens, H.P. Kohler, M.W. Mansfield, P.J. Grant Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: relation to sex, age, smoking, and hypertension Arterioscler Thromb Vasc Biol 19 1999 2012 2016
26. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
27. A.M. Carter, M.W. Mansfield, M.H. Stickland, P.J. Grant Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels: risk factors for coronary artery disease in subjects with NIDDM Diabetes Care 19 1996 1265 1268
28. D.M. Heywood, M.W. Mansfield, P.J. Grant Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin dependent diabetes mellitus Thromb Haemost 75 1996 401 406
29. M. de Lange, H. Snieder, R.A. Ariens, T.D. Spector, P.J. Grant The genetics of haemostasis: a twin study Lancet 357 2001 101 105
30. R.A. Ariens, M. de Lange, H. Snieder, M. Boothby, T.D. Spector, P.J. Grant Activation markers of coagulation and fibrinolysis in twins: heritability of the pre-thrombotic state Lancet 359 2002 667 671
31. E.B. Smith, G.A. Keen, A. Grant, C. Stirk Fate of fibrinogen in human arterial intima Arteriosclerosis 10 1990 263 275
32. F.B. Smith, A.J. Lee, C.M. Hau, A. Rumley, G.D. Lowe, F.G. Fowkes Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study Blood Coagul Fibrinolysis 11 2000 43 50
33. F.B. Smith, A.J. Lee, F.G.R. Fowkes, J.F. Price, A. Rumley, G.D.O. Lowe Haemostatic factors as predictors of ischaemic heart disease and stroke in the Edinburgh Artery Study Arterioscler Thromb 17 1997 3321 3325
34. G.D.O. Lowe, F.G.R. Fowkes, J. Dawes, P.T. Donnan, S.E. Lennie, E. Housley Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study Circulation 87 1993 1915 1920
35. K. Fatah, A. Silveira, P. Tornvall, F. Karpe, M. Blomback, A. Hamsten Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age Thromb Haemost 76 1996 535 540
36. J.D. Mills, R.A. Ariens, M.W. Mansfield, P.J. Grant Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease Circulation 106 2002 1938 1942
37. J.S. Yudkin Abnormalities of coagulation and fibrinolysis in insulin resistance: evidence for a common antecedent? Diabetes Care 22 suppl 3 1999 C25 30
38. J.S. Zebrack, J.L. Anderson The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease Curr Cardiol Rep 4 2002 278 288
39. Factor VII. In: Tuddenham EGD, Cooper DN, editors. The molecular genetics of haemostasis and its inherited disorders. Oxford, England: Oxford University Press; 1994. p 271-83.
40. M. Cortellaro, C. Boschetti, E. Cofrancesco, C. Zanussi, M. Catalano, G. deGaetano The PLAT Study Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results Progetto Lombardo Atero-Trombosi (PLAT) Study Group Arterioscler Thromb 12 1992 1063 1070
41. J.B. Meigs, M.A. Mittleman, D.M. Nathan, G.H. Tofler, D.E. Singer, P.M. Murphy-Sheehy Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study JAMA 283 2000 221 228
42. S.E. Humphries, A. Lane, F.R. Green, J. Cooper, G.J. Miller Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration Arterioscler Thromb 14 1994 193 198
43. L. Muszbek, R. Adany, H. Mikkola Novel aspects of blood coagulation factor XIII I: Structure, distribution, activation, and function Crit Rev Clin Lab Sci 33 1996 357 421
44. G.L. Reed, A.K. Houng The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism Circulation 99 1999 299 304
45. C.W. Francis, D.G. Connaghan, W.L. Scott, V.J. Marder Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction Circulation 75 1987 1170 1177
46. J. Kloczko, M. Wojtukiewicz, M. Bielawiec, A. Zuch Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis Thromb Res 51 1988 575 581
47. R.J. Shebuski, G.R. Sitko, D.A. Claremon, J.J. Baldwin, D.C. Remy, A.M. Stern Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue- type plasminogen activator Blood 75 1990 1455 1459